Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR 1,255.20
+29.80 (2.43%)
Jul 31, 2026, 3:29 PM IST
Zota Health Care Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 44,305 | 35,962 | 20,263 | 11,939 | 7,089 | 7,488 | |
Market Cap Growth | 42.60% | 77.48% | 69.73% | 68.41% | -5.33% | 120.12% |
Enterprise Value | 46,081 | 37,745 | 21,342 | 12,425 | 7,426 | 7,312 |
Last Close Price | 1279.30 | 1064.80 | 804.79 | 473.41 | 280.39 | 294.72 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 84.06 |
PS Ratio | 8.23 | 6.68 | 6.92 | 6.62 | 5.04 | 5.70 |
PB Ratio | 6.36 | 5.17 | 8.92 | 13.27 | 8.82 | 8.35 |
P/TBV Ratio | 6.56 | 5.33 | 9.26 | 13.90 | 9.32 | 8.90 |
P/FCF Ratio | - | - | - | - | - | 74.25 |
P/OCF Ratio | - | - | - | - | - | 56.16 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 8.55 | 7.01 | 7.29 | 6.88 | 5.28 | 5.57 |
EV/EBITDA Ratio | 248.55 | 203.59 | - | - | 2620.16 | 51.95 |
EV/EBIT Ratio | - | - | - | - | - | 65.26 |
EV/FCF Ratio | - | - | - | - | - | 72.52 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.39 | 0.39 | 0.62 | 1.06 | 0.56 | 0.17 |
Debt / EBITDA Ratio | 14.59 | 14.59 | - | 12.73 | 5.61 | 1.01 |
Debt / FCF Ratio | - | - | - | - | - | 1.48 |
Net Debt / Equity Ratio | 0.25 | 0.25 | 0.60 | 1.05 | 0.55 | 0.14 |
Net Debt / EBITDA Ratio | 9.43 | 9.43 | -4.04 | -14.94 | 155.28 | 0.90 |
Net Debt / FCF Ratio | -0.89 | -0.89 | -1.42 | -4.15 | -3.03 | 1.25 |
Asset Turnover | 0.69 | 0.69 | 0.88 | 0.93 | 0.95 | 1.17 |
Inventory Turnover | 1.43 | 1.43 | 1.74 | 2.03 | 2.36 | 3.04 |
Quick Ratio | 0.71 | 0.71 | 0.46 | 0.47 | 0.76 | 1.10 |
Current Ratio | 1.93 | 1.93 | 1.83 | 1.52 | 2.08 | 2.14 |
Return on Equity (ROE) | -16.05% | -16.05% | -35.78% | -16.85% | -6.79% | 11.43% |
Return on Assets (ROA) | -5.09% | -5.09% | -8.98% | -4.05% | -1.61% | 6.24% |
Return on Invested Capital (ROIC) | -9.37% | -10.36% | -17.51% | -8.12% | -3.38% | 9.60% |
Return on Capital Employed (ROCE) | -7.20% | -7.20% | -14.20% | -8.10% | -3.30% | 10.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -1.67% | -2.06% | -2.78% | -1.20% | -0.81% | 1.19% |
FCF Yield | -4.45% | -5.49% | -4.74% | -1.90% | -2.05% | 1.35% |
Dividend Yield | 0.08% | 0.09% | 0.12% | 0.21% | 0.36% | 0.51% |
Payout Ratio | - | - | - | - | - | 28.25% |
Buyback Yield / Dilution | -20.72% | -20.72% | -6.33% | -1.93% | -1.11% | -1.32% |
Total Shareholder Return | -20.64% | -20.63% | -6.21% | -1.71% | -0.75% | -0.81% |